As one of 200 awardees of the 2019 ERC Proof-of-concept grant, Prof. Ilja Voets will be in the lead of the PEPTOX project. The study will focus on innovative peptide systems for novel drugs that target microbial RTX adhesins and may help to cure infectious diseases, such as cholera, in the future.
